Φορτώνει......

The Epithelial Barrier Model Shows That the Properties of VSL#3 Depend from Where it is Manufactured

BACKGROUND: VSL#3 has been extensively investigated and is currently recommended for the prevention and treatment of chronic pouchitis and ulcerative colitis. Nonetheless, in vitro and in vivo stud-ies have recently shown variability in the VSL#3 efficacy often attributed to the manufacturing proces...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Endocr Metab Immune Disord Drug Targets
Κύριοι συγγραφείς: Palumbo, Paola, Lombardi, Francesca, Cifone, Maria Grazia, Cinque, Benedetta
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Bentham Science Publishers 2019
Θέματα:
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6425067/
https://ncbi.nlm.nih.gov/pubmed/30360752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1871530318666181022164505
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!